US Patent 9642921 Cancer combination therapy and recombinant vectors
Patent 9642921 was granted and assigned to Tocagen on May, 2017 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
December 20, 2013
Date of Patent
May 9, 2017
Patent Applicant
Patent Application Number
14137803
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 9642921 Cancer combination therapy and recombinant vectors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.